Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project (HEAL)

November 28, 2023 updated by: Rachel Keith, University of Louisville
The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

835

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Kentucky
      • Louisville, Kentucky, United States, 40202
        • Recruiting
        • University of Louisville
        • Contact:
        • Principal Investigator:
          • Rachel Keith, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 30-70 years of age.
  • Live within the targeted study location

Exclusion Criteria:

  • Unwilling or unable to provide consent.
  • HIV/AIDS, active treatment for cancer, active bleeding including wounds.
  • Body weight less than 100 pounds or BMI>40.
  • Prisoners and other vulnerable populations.
  • Anyone that PI thinks is unsafe to participate in study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
No intervention
Experimental: Targeted neighborhoods for Greenness
Using greenness as a therapeutic intervention, we will plant shrubs, grasses, young and mature trees (40-50 ft in height), so that we can evaluate changes in health and pollution, 2 years after planting.
Greenness to be used as a therapeutic intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiovascular Measurements. Change from Baseline Systolic and Diastolic pressures at baseline and 2 year followup.
Time Frame: Baseline and 2 year followup
Blood pressure mm Hg
Baseline and 2 year followup

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulse Wave Analysis. Assess change from baseline arterial stiffness measurement and 2 year followup.
Time Frame: Baseline and 2 year followup
Augmentation index-percent
Baseline and 2 year followup
Physical Exam
Time Frame: Baseline and 2 year followup
Body weight-pounds
Baseline and 2 year followup
Body lean mass
Time Frame: Baseline and 2 year followup
Body lean mass to be measured in pounds
Baseline and 2 year followup
Body fat
Time Frame: Baseline and 2 year followup
Body fat to be measured in percentage
Baseline and 2 year followup
Standing height
Time Frame: Baseline and 2 year followup
standing height reported in inches
Baseline and 2 year followup
Waist, Hip measurement
Time Frame: Baseline and 2 year followup
central adiposity (waist circumference, and hip circumference to be measured in inches
Baseline and 2 year followup
Respiratory status will be evaluated
Time Frame: Baseline and 2 year followup
Fleisch-type pneumotachometer used to evaluate FEV1 and FVC percentages
Baseline and 2 year followup
Bucchal swab
Time Frame: Baseline and 2 year followup
Assess oral microbiome and DNA from cheek swab will be stored for genetic phenotyping.
Baseline and 2 year followup
Urine collection
Time Frame: Baseline and 2 year followup
metabolites of environmental volatile organic compounds ng/mg creatinine, biogenic VOCs and nicotine metabolites ng/mg creatinine, catecholamines ng/mg creatinine
Baseline and 2 year followup
Lipids
Time Frame: Baseline and 2 year followup
LDL-mg/dl, HDL-mg/dl, total cholesterol-mg/dl
Baseline and 2 year followup
Toenail samples
Time Frame: Baseline and 2 year followup
Toenail samples to look for heavy metal exposure
Baseline and 2 year followup
Hair samples
Time Frame: Baseline and 2 year followup
Hair samples to look at cortisol levels over time.
Baseline and 2 year followup
Perceived stress scale-PSS-10 range 0-40
Time Frame: Baseline and 2 year followup
The higher the score the more perceived stress
Baseline and 2 year followup
Depression-Patient Health Questionnaire (PHQ-9) 0-27
Time Frame: Baseline and 2 year followup
The 0-4= none; 5-9= Mild, 10-14= Moderate; 15-19= moderately severe; 20-27= severe. The higher the score the more severe the depression.
Baseline and 2 year followup
Well-being assessment-Questionnaire 13-65
Time Frame: Baseline and 2 year followup
Warwick-Edinburgh Mental Well-being scale 13-65. The higher the score the higher the sense of well-being.
Baseline and 2 year followup
Health perception
Time Frame: Baseline and 2 year followup
Health perception questionnaire
Baseline and 2 year followup
National Health Interview Survey tobacco questionnaire
Time Frame: Baseline and 2 year followup
National Health Interview Survey tobacco questionnaire
Baseline and 2 year followup
The Alcohol Use disorders identification test (AUDIT)- Range 0-40
Time Frame: Baseline and 2 year followup
Scores of 8-15 or more are recommended indicators of hazardous and harmful alcohol use or possible alcohol dependence. Women can be lowered to a score of 7 for concern. Scores of 16-19 suggest a need for brief counseling and continues monitoring. Scores of 20 or above warrant diagnostic evaluation for alcohol dependence.
Baseline and 2 year followup
Self reported physical activity 1
Time Frame: Baseline and 2 year followup
times per week
Baseline and 2 year followup
Self reported physical activity 2
Time Frame: Baseline and 2 year followup
Exertion level of mild moderate or vigorous
Baseline and 2 year followup
Self reported education
Time Frame: Baseline and 2 year followup
Education to be reported by last school grade completed
Baseline and 2 year followup
Self reported annual income
Time Frame: Baseline and 2 year followup
Annual income reported by dollars
Baseline and 2 year followup
Platelet count
Time Frame: Baseline and 2 year followup
cells/cubic millimeter
Baseline and 2 year followup
Complete Blood Count 1
Time Frame: Baseline and 2 year followup
White/Red blood cell count- cells per cubic millimeter
Baseline and 2 year followup
Complete Blood Count 2
Time Frame: Baseline and 2 year followup
Hemoglobin-grams/deciliter
Baseline and 2 year followup
Complete Blood Count 3
Time Frame: Baseline and 2 year followup
Hematocrit-percentage
Baseline and 2 year followup
Liver function
Time Frame: Baseline and 2 year followup
AST, ALT units per liter
Baseline and 2 year followup
C-Reactive Protein
Time Frame: Baseline and 2 year followup
Hs-CRP-mg/Liter
Baseline and 2 year followup

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Aruni Bhatnagar, PhD, University of Louisville
  • Principal Investigator: Rachel Keith, PhD, University of Louisville

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 3, 2018

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

August 31, 2018

First Submitted That Met QC Criteria

September 12, 2018

First Posted (Actual)

September 13, 2018

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 28, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15.1260
  • R01ES029846-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Greenness as a therapeutic intervention

3
Subscribe